Genetic basis of bilateral renal cancer: Implications for evaluation and management

Journal of Clinical Oncology

Volumn 27, Issue 23, 2009, Pages 3731-3733

  Linehan, W Marston ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR RECEPTOR; SUCCINATE DEHYDROGENASE; FLCN PROTEIN, HUMAN; ONCOPROTEIN; SDHB PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ANGIOMYOLIPOMA; BILATERAL CANCER; BIRT HOGG DUBE SYNDROME; CANCER GENETICS; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RISK; CHILDHOOD CANCER; CLEAR CELL CARCINOMA; EDITORIAL; FAMILIAL CANCER; FAMILY HISTORY; GENETIC PREDISPOSITION; HEREDITARY LEIOMYOMATOSIS RENAL CELL CARCINOMA; HEREDITARY PAPILLARY RENAL CARCINOMA; HISTOLOGY; HUMAN; KIDNEY CANCER; KIDNEY CARCINOMA; KIDNEY CYST; KIDNEY METASTASIS; LEIOMYOMATOSIS; ONCOCYTOMA; PARAGANGLIOMA; PHENOTYPE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; TUBEROUS SCLEROSIS; TUMOR GENE; VON HIPPEL LINDAU DISEASE; GENETICS; ICELAND; INCIDENCE; KIDNEY TUMOR; MULTIPLE CANCER; MUTATION; NORWAY; NOTE; SECOND CANCER; SWEDEN;

CARCINOMA, RENAL CELL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ICELAND; INCIDENCE; KIDNEY NEOPLASMS; LEIOMYOMATOSIS; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; NORWAY; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PROTO-ONCOGENE PROTEINS; SUCCINATE DEHYDROGENASE; SWEDEN; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS; VON HIPPEL-LINDAU DISEASE;

EID: 68949102179     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.23.0045     Document Type: Editorial

References (35)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58:71-96, 2008
2. Wiklund F, Tretli S, Choueiri TK, et al: Risk of bilateral renal cell cancer. J Clin Oncol 27:3737-3741, 2009
3. Walther MM, Lubensky IA, Venzon D, et al: Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: Clinical implications. J Urol 154:2010-2014, 1995
4. Vocke CD, Yang Y, Pavlovich CP, et al: High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors. J Natl Cancer Inst 97:931-935, 2005
5. Gudbjartsson T, Jonasdottir TJ, Thoroddsen A, et al: A population-based familial aggregation analysis indicates genetic contribution in a majority of renal cell carcinomas. Int J Cancer 100:476-479, 2002
6. Linehan WM, Walther MM, Zbar B: The genetic basis of cancer of the kidney. J Urol 170:2163-2172, 2003
7. Linehan WM, Zbar B: Focus on kidney cancer. Cancer Cell 6:223-228, 2004
8. Linehan WM, Pinto PA, Srinivasan R, et al: Identification of the genes for kidney cancer: Opportunity for disease-specific targeted therapeutics. Clin Cancer Res 13:671s-679s, 2007
9. Latif F, Tory K, Gnarra JR, et al: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320, 1993
10. Linehan WM, Lerman MI, Zbar B: Identification of the VHL gene: Its role in renal carcinoma. JAMA 273:564-570, 1995
11. Lonser RR, Glenn GM, Walther MM, et al: von Hippel-Lindau disease. Lancet 361:2059-2067, 2003
12. Butman JA, Linehan WM, Lonser RR: Neurologic manifestations of von Hippel-Lindau disease. JAMA 300:1334-1342, 2008
13. Zbar B, Tory K, Merino MJ, et al: Hereditary papillary renal cell carcinoma. J Urol 151:561-566, 1994
14. Zbar B, Glenn GM, Lubensky IA, et al: Hereditary papillary renal cell carcinoma: Clinical studies in 10 families. J Urol 153:907-912, 1995
15. Schmidt L, Duh FM, Chen F, et al: Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16:68-73, 1997
16. Schmidt L, Junker K, Weirich G, et al: Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. Cancer Res 58:1719-1722, 1998
17. Birt AR, Hogg GR, Dube WJ: Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 113:1674-1677, 1977
18. Zbar B, Alvord WG, Glenn GM, et al: Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome. Cancer Epidemiol Biomarkers Prev 11:393-400, 2002
19. Nickerson ML, Warren MB, Toro JR, et al: Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell 2:157-164, 2002
20. Schmidt LS, Nickerson ML, Warren MB, et al: Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome. Am J Hum Genet 76:1023-1033, 2005
21. Pavlovich CP, Grubb RL, Hurley K, et al: Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome. J Urol 173:1482-1486, 2005
22. Weirich G, Glenn GM, Junker K, et al: Familial renal oncocytoma: Clinicopathological study of 5 families. J Urol 160:335-340, 1998
23. Cheadle JP, Reeve MP, Sampson JR, et al: Molecular genetic advances in tuberous sclerosis. Hum Genet 107:97-114, 2000
24. Crino PB, Nathanson KL, Henske EP: The tuberous sclerosis complex. N Engl J Med 355:1345-1356, 2006
25. Launonen V, Vierimaa O, Kiuru M, et al: Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A 98:3387-3392, 2001
26. Tomlinson IP, Alam NA, Rowan AJ, et al: Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406-410, 2002
27. Toro JR, Nickerson ML, Wei MH, et al: Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 73:95-106, 2003
28. Grubb RL III, Franks ME, Toro J, et al: Hereditary leiomyomatosis and renal cell cancer: A syndrome associated with an aggressive form of inherited renal cancer. J Urol 177:2074-2080, 2007
29. Merino MJ, Torres-Cabala C, Pinto P, et al: The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 31:1578-1585, 2007
30. Baysal BE, Ferrell RE, Willett-Brozick JE, et al: Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287:848-851, 2000
31. Baysal BE: Clinical and molecular progress in hereditary paraganglioma. J Med Genet 45:689-694, 2008
32. Neumann HP, Pawlu C, Peczkowska M, et al: Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292:943-951, 2004
33. Vanharanta S, Buchta M, McWhinney SR, et al: Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet 74:153-159, 2004
34. Ricketts C, Woodward ER, Killick P, et al: Germline SDHB mutations and familial renal cell carcinoma. J Natl Cancer Inst 100:1260-1262, 2008
35. Henderson A, Douglas F, Perros P, et al: SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis. Fam Cancer doi: 10.1007/s10689-009-9234-2